Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats

Brain Research

Volumn 731, Issue 1-2, 1996, Pages 31-38

  Cervo, Luigi ^a   Samanin, Rosario ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

( ) sulpiride; Cocaine; Conditioned locomotion; DNQX; MK 801; Rat; SCH 23390

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; COCAINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030603112     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00455-6     Document Type: Article

References (36)

1. [1] Barr, G.A., Sharpless, N.S., Cooper, S. and Schiff, S.R., Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy, Life Sci., 33 (1983) 1341-1351.
2. [2] Beninger, R.J. and Hanh, B.L., Pimozide blocks the establishment but not expression of amphetamine-produced environment-specific conditioning, Science, 220 (1983) 1304-1306.
3. [3] Beninger, R.J. and Herz, R.S., Pimozide blocks the establishment but not expression of cocaine-produced environment-specific conditioning, Life Sci., 38 (1986) 1425-1431.
4. 2) receptors. Eur. J. Pharmacol., 129 (1986) 367-370.
5. [5] Brown, E.E. and Fibiger, H.C., Cocaine-induced conditioned locomotion: absence of associated increases in dopamine release. Neuroscience, 48 (1992) 621-629.
6. [6] Brown, E.E., Robertson, G.S. and Fibiger, H.C., Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures, J. Neurosci., 12 (1992) 4112-4121.
7. [7] Cervo, L. and Samanin, R., Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference, Brain Res., 673 (1995) 242-250.
8. [8] Dai, H. and Carey, R.J., The NMDA antagonist MK-801 can impair attention to exteroceptive stimuli, Behav. Brain Res., 62 (1994) 149-156.
9. 2 receptor function, Pharmacol. Biochem. Behav., 41 (1992) 519-527.
10. [10] Hand, T.H., Stinus, L. and Le Moal, M., Differential mechanisms in the acquisition and expression of heroin-induced place preference, Pschopharmacology. 98 (1989) 61-67.
11. [11] Hiroi, N. and White, N.M., The amphetamine conditioned place preference: differential involvement of dopaminergic receptor subtypes and two dopaminergic terminal areas, Brain Res., 552 (1991) 141-152.
12. [12] Hoffman, D.C., The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats, Pharmacol. Biochem. Behav., 47 (1994) 907-912.
13. [13] Honoré, T., Davies, S.N., Dreijer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. and Nielsen, F.E., Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonist, Science, 241 (1988) 701-703.
14. [14] Hyttel, J., SCH 23390 the first selective D-1 antagonist, Eur. J. Pharmacol., 91 (1983) 153-154.
15. [15] Lorio, L.C., Barnett, A., Leitz, F.M., Houser, V.P. and Korduba, C.A., SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic system, J. Pharmacol. Exp. Ther., 226 (1983) 462-468.
16. [16] Jenner, P. and Marsden, C.D., The mechanism of action of substituted benzamide drugs. In P.F. Spano, M. Trabucchi, G.U. Corsini and G.L. Gessa (Eds.). Sulpiride and Other Benzamides, Italian Brain Research Foundation. Milan. 1979. pp. 119-147.
17. [17] Kaddis, F.G., Wallace, L.J. and Uretsky, N.J., AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists, Pharmacol. Biochem. Behav., 46 (1993) 703-708.
18. [18] Karler, R., Calder, L.D. and Bedingfield, J.B., Cocaine behavioral sensitization and the excitatory amino acids, Psychopharmacology, 115 (1994) 305-310.
19. [19] Karler, R., Calder, L.D., Chaundry, I.A. and Turkanis, S.A., Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci., 45 (1989) 599-606.
20. [20] Karler, R., Calder, L.D. and Turkanis, S.A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552 (1991) 295-300.
21. [21] Layer, R.T., Uretsky, N.J. and Wallace, L.J., Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference, Brain Res., 617 (1993) 267-273.
22. [22] Ljungberg, T. and Ungerstedt, U., Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action, Psychopharmacology, 56 (1978) 239-247.
23. [23] Markou, A., Weiss, F., Gold, L., Barak Caine, S., Schulteis, G. and Koob, G.F., Animal models of drug-craving, Psychopharmacology, 112 (1993) 163-182.
24. 2 dopamine receptors during conditioning, Brain Res., 521 (1990) 175-184.
25. [25] Martin-Iverson, M.T. and Reimer, A.R., Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats, Psychopharmacology, 114 (1994) 315-320.
26. [26] Neisewander, J.L., Pierce, R.C. and Bardo, M.T., Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology, 100 (1990) 201-205.
27. [27] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press. Australia, 1986.
28. [28] Poncelet, M., Dangoumau, P., Soubrié, P. and Simon, P., Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats, Psychopharmacology, 92 (1987) 393-397.
29. [29] Pugh, M.T., O'Boyle, K.M., Molloy, A.G. and Waddington, J.L., Effects of the putative D-1 antagonist SCH23390 on stereotyped behavior induced by the D-2 agonist RU24213, Psychopharmacology, 92 (1987) 308-312.
30. [30] Reimer, A.R. and Martin-Iverson, M.T., Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine, Psychopharmacology, 113 (1994) 404-410.
31. [31] Robinson, T.E. and Berridge, K.C., The neural basis of drug-craving: an incentive-sensitization theory of addiction, Brain Res. Rev., 18 (1993) 247-291.
32. [32] Stewart, J. and Durban, J.P., Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801, Psychopharmacology, 110 (1993) 125-132.
33. [33] Tatum, A.L. and Seevers, M.H., Experimental cocaine addiction, J. Pharmacol Exp. Ther., 36 (1929) 401-410.
34. [34] Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
35. [35] Wolf, M.E., Xue, C.-J., White, F.J. and Dahlin, S.L., MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res., 666 (1994) 223-231.
36. [36] Wong, E.H.F., Kemp, J.A., Pristly, T., Knight, A.R., Woodruff, G.N. and Iversen, L.L., The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA, 83 (1986) 7104-7108.